Furthermore, metabolite profiling has shown that glutamine is among the most depleted metabolites in MYC-driven liver tumors, whereas glutamate, the product of the first step of glutaminolysis, is abundant in tumor tissue compared to normal liver, which could be explained by the MYC-dependent upregulation of GLS [54]. Here, GLS is linked to neoplasm.